Key points are not available for this paper at this time.
The pharmacological management of hyperkalemia traditionally considered calcium or sodium polystyrene sulfonate (SPS) and, since recently, the novel binders patiromer and sodium zirconium cyclosilicate (SZC). We evaluated their patterns of use, duration of treatment and relative effectiveness/safety in Swedish routine care.
Ortiz et al. (Mon,) studied this question.